Acquiring Company
Leyden Labs
Acquired Company
RIGImmune
Description
Leyden Labs has officially acquired RIGImmune, expanding its pipeline into mucosal protection therapies. The acquisition was confirmed in an email to European Biotechnology, with Leyden noting that it complements their existing approach. RIGImmune's technology is expected to play a key role in Leyden's development strategy. Financial details were not disclosed, but prior filings indicate share exchanges as part of the acquisition.
Don't miss Leyden Labs's next move
Get an email the moment Leyden Labs makes an acquisition, hires an exec, or expands, usually minutes after it happens.
One email per event. Unsubscribe anytime.
Related People
M&A Insights
Based on deal dataFrequently asked
Who acquired RIGImmune?
RIGImmune was acquired by Leyden Labs. The deal was reported on September 9, 2026. The platform will also support development of novel broad-protection nasal sprays for coronavirus family and other respiratory diseases. Leyden Labs is privately held and operates in Science And Engineering.
When did Leyden Labs acquire RIGImmune?
Leyden Labs's acquisition of RIGImmune was reported on September 9, 2026. Leyden Labs has officially acquired RIGImmune, expanding its pipeline into mucosal protection therapies. The acquisition was confirmed in an email to European Biotechnology, with Leyden noting that it complements their existing approach. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does RIGImmune do?
RIGImmune is a platform biopharmaceutical company developing a novel investigational class of RNA immunotherapies termed “SLRs” for the potential pan-viral treatment and prophylaxis of viral respiratory diseases and selected cancers. It is privately held, operating in Biotechnology, and is based in Farmington.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.